Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection
Clinical trial NCT07077798 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07077798
- Sponsor
- Wan-Guang Zhang
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-08-31
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.